Does Mounjaro® Cause Cancer? Understanding the Science

Key Takeaways For Safe & Effective Mounjaro® Use

While the question of whether Mounjaro® increases the risk of cancer remains under investigation, current evidence does not point to a direct link. Ongoing research and post-marketing surveillance are vital for providing more definitive answers. Patients considering Mounjaro® for weight loss or diabetes management should consult with their healthcare providers to weigh the benefits and potential risks, including cancer. Making informed healthcare decisions involves considering the broader spectrum of available medications and their safety profiles, always in the context of individual health needs and concerns.

Connect with a Mochi Health provider for tailored guidance from an obesity medicine specialist. Our program at Mochi Health includes personalized weight care, access to GLP-1 medications, and expert support every step of the way. Check your eligibility and start your health transformation today.

References:

1. Chiu, W.-Y., Shih, S.-R., & Tseng, C.-H. (2012). A Review on the Association between Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer. Experimental Diabetes Research, 2012, 924168–7. https://doi.org/10.1155/2012/924168

2. Nagendra, L., BG, H., Sharma, M., & Dutta, D. (2023). Semaglutide and cancer: A systematic review and meta-analysis. Diabetes & Metabolic Syndrome Clinical Research & Reviews, 17(9), 102834–102834. https://doi.org/10.1016/j.dsx.2023.102834

3. Wang, L., Wang, W., Kaelber, D. C., Xu, R., & Berger, N. A. (2024). GLP-1 Receptor Agonists and Colorectal Cancer Risk in Drug-Naive Patients With Type 2 Diabetes, With and Without Overweight/Obesity. JAMA Oncology, 10(2), 256–258. https://doi.org/10.1001/jamaoncol.2023.5573

4.https://Mounjaro®.lilly.com/hcp/a1c-weight?gad_source=1&gclid=CjwKCAjwz42xBhB9EiwA48pT75Ii6HeqixGhyuhbXnRXe5JMGADJHHjK0_BWgPCa9aY3rV3aJoz1GBoCV3AQAvD_BwE#mounjaro-a1c

5. https://www.cdc.gov/cancer/risk-factors/obesity.html

6. Fareed, A., & Hussain, A. (2023). The Expanding Role of GLP-1: From Diabetes Management to Cancer Treatment. Clinical Medicine Insights. Endocrinology and Diabetes, 16, 11795514231213566–11795514231213566. https://doi.org/10.1177/11795514231213566

7. Tong, G., Peng, T., Chen, Y., Sha, L., Dai, H., Xiang, Y., Zou, Z., He, H., & Wang, S. (2022). Effects of GLP-1 Receptor Agonists on Biological Behavior of Colorectal Cancer Cells by Regulating PI3K/AKT/mTOR Signaling Pathway. Frontiers in Pharmacology, 13, 901559–901559. https://doi.org/10.3389/fphar.2022.901559

This post was written by our team of health writers for informational purposes only and does not constitute medical advice. Always consult your doctor or healthcare provider for personalized guidance regarding your health. Ozempic®, Wegovy®, Mounjaro®, and Zepbound® and their delivery device are registered trademarks. Mochi Health is a telehealth clinic that offers prescriptions for these products by medical necessity only as determined by a licensed health provider.